Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/21/2008WO2008098634A1 Dermal film-forming liquid formulations for drug release to skin
08/21/2008WO2008098586A1 Pharmaceutical carrier composition and pharmaceutical composition
08/21/2008WO2008098485A1 The salts of 4-aniline quinazoline derivative
08/21/2008WO2008098471A1 A crystalline form of entecavir, its preparation, pharmaceutical compositions thereof and uses
08/21/2008WO2008098427A1 Use of ethyl piperic acid ester in preparation of medicament or healthcare product for the prevention and/or treatment of atherosclerosis
08/21/2008WO2008098415A1 Pharmaceutical composition containing taxane and its preparation process and application
08/21/2008WO2008098379A1 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
08/21/2008WO2008098375A1 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
08/21/2008WO2008098374A1 Salts, prodrugs and polymorphs of fab i inhibitors
08/21/2008WO2008098371A1 Compositions and method for reducing amyloid beta in a mammal
08/21/2008WO2008098364A1 Reducing post-operative adhesion formation with intraperitoneal glutamine
08/21/2008WO2008098351A1 Treatment of d-cyclin mediated proliferative diseases and hemotological malignancies
08/21/2008WO2008098329A2 Pharmaceutical composition, pharmaceutical product, obtaining processes of pharmaceutical compounds and use of such compounds for treating erectile dysfunction
08/21/2008WO2008098325A1 Pharmaceutical composition on the basis of stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo
08/21/2008WO2008098304A1 Carborane-phosphonium compounds and their use in boron neutron capture therapy and imaging
08/21/2008WO2008085310A3 Effervescent formulations of florfenicol for addition in drinking water systems
08/21/2008WO2008083158A3 Topical administration of danazol
08/21/2008WO2008081096A3 Quinolinyl derivatives, method for preparing same, pharmaceutic compositions containing same, and use thereof as hypoglycemiant and hypolipemiant agents
08/21/2008WO2008080134A3 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
08/21/2008WO2008079629A3 Formulations with improved bioavailability
08/21/2008WO2008078305A3 4-(1-amino-ethyl)-cyclohexylamine derivatives
08/21/2008WO2008078305A2 4-(1-amino-ethyl)-cyclohexylamine derivatives
08/21/2008WO2008077057A3 Cytoskeletal active rho kinase inhibitor compounds, composition and use
08/21/2008WO2008076348A8 Crystalline solid rasagiline base
08/21/2008WO2008076269A3 MONOPHOSPHATES AS MUTUAL PRODRUGS OF MUSCARINIC RECEPTOR ANTAGONISTS AND β-AGONISTS FOR THE TREATMENT OF COPD AND CHRONIC BRONCHITIS
08/21/2008WO2008076251A9 Biocidal composition and method for treating recirculating water systems
08/21/2008WO2008075321A3 Modified-release formulations of azabicyclo derivatives
08/21/2008WO2008075184A3 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them
08/21/2008WO2008075148A3 Tricyclic inhibitors of carbonic anhydrase
08/21/2008WO2008070726A3 Treatment for dry eye
08/21/2008WO2008070000A3 Treatment of anxiety with eszopiclone
08/21/2008WO2008069922A9 Compositions including triciribine and anthracyclin analogs and methods of use thereof
08/21/2008WO2008068614A3 Stereoselective synthesis of 1-[6-ethyl-1,2-dihydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one
08/21/2008WO2008067995A8 Means and method for raising improved immune response
08/21/2008WO2008067144A3 Cancer treatment method
08/21/2008WO2008067119A3 Novel compounds
08/21/2008WO2008066789A3 Heteroaryl amide derivatives
08/21/2008WO2008066641A3 Methods for treating mitf associated diseases by the use of methionine aminopeptidase-2 inhibitors
08/21/2008WO2008064310A3 Mixed opioid receptor active compounds
08/21/2008WO2008064302A3 Methods for reducing circulating glucose levels
08/21/2008WO2008064244A9 Phosphoinositide modulation for the treatment of neurodegenerative diseases
08/21/2008WO2008064217A9 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and pharmaceutical formulations thereof
08/21/2008WO2008061724A3 Compositions comprising carnosic acid 12-methylether
08/21/2008WO2008060581A3 Compositions including triciribine and trastuzumab and methods of use thereof
08/21/2008WO2008060568A3 Amide-substituted aryl piperidines
08/21/2008WO2008060441A3 Stable amifostine liquid concentrate
08/21/2008WO2008057855A3 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity
08/21/2008WO2008057291B1 Crystalline and amorphous imatinib base, imatinib mesylate- and processes for preparation thereof
08/21/2008WO2008055146A9 Formulations of phospholipase enzyme inhibitors
08/21/2008WO2008053393A8 Rotary actuator
08/21/2008WO2008051523A3 Carbazole derivatives useful as medicaments in cancer therapy
08/21/2008WO2008049424A3 Pharmaceutical composition for the treatment of allergic diseases
08/21/2008WO2008048695A3 Synthesis and applications of nanomaterials derived from self-assembled diacetylenic triglycerides
08/21/2008WO2008046003A3 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
08/21/2008WO2008045558A3 Benzothiadiazine compounds and their use
08/21/2008WO2008045273A3 Camkk(beta) as a target for treating obesity
08/21/2008WO2008036134A3 Method of inhibiting the transmission of influenza virus
08/21/2008WO2008034736A3 Oxindole derivatives as anticancer agents
08/21/2008WO2008031550A3 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors
08/21/2008WO2008030891A3 Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof
08/21/2008WO2008026234A3 Method to identify and treat subjects resistant to acetyl salicylic acid
08/21/2008WO2008025787A3 Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
08/21/2008WO2008024978A3 Tetrahydroindolone and tetrahydroindazolone derivatives
08/21/2008WO2008016593A3 Bioactive depside and anthocyanin compounds, compositions, and methods of use
08/21/2008WO2008011016A3 Treating gastroesophageal reflux disease with 5-ht3- and gaba receptor agonists
08/21/2008WO2008006071A3 Blends of fullerene derivatives, and uses thereof in electronic devices
08/21/2008WO2008005084B1 Methods to prevent and treat diseases
08/21/2008WO2007146425A3 Compounds and methods for treatment of chemotherapy-induced anemia
08/21/2008WO2007145922A3 Benzazepinones as sodium channel blockers
08/21/2008WO2007144196A3 Peptide compounds for treating refractory status epilepticus
08/21/2008WO2007139955A3 Triazole compounds that modulate hsp90 activity
08/21/2008WO2007121418A3 Chemical compounds
08/21/2008WO2007120690A3 Combination histamine h1r and h4r antagonist therapy for treating pruritus
08/21/2008WO2007120665A3 Formulation and method for a skin treatment for animals
08/21/2008WO2007117791A3 Combination treatment of metabolic disorders
08/21/2008WO2007112274A3 Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin
08/21/2008WO2007109783A3 Substituted pyrimidine kinase inhibitors
08/21/2008WO2007109350A3 Modulation of innate immunity receptors' signaling by micrornas mir-146a and mir-146b
08/21/2008WO2007103638A3 Hormone replacement formulation
08/21/2008WO2007100695A3 Metabolic regulators and uses thereof
08/21/2008WO2007100430A3 Cytisine and acetylcholine analogs and methods of treating mood disorders
08/21/2008WO2007090162A3 OXYLIPINS FROM STEARIDONIC ACID AND γ-LINOLENIC ACID AND METHODS OF MAKING AND USING THE SAME
08/21/2008WO2007089562A3 Compositions and methods for the treatment of viral infections
08/21/2008WO2007062151A3 Chemical compounds
08/21/2008WO2007045962A3 Novel hdac inhibitors
08/21/2008WO2007037898A8 Theramutein modulators
08/21/2008WO2007020261A3 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
08/21/2008US20080200924 Methods for minimally invasive, non-permanent occlusion of a uterine artery
08/21/2008US20080200848 Vibrating Device For Treating Nasal Congestion and Sinusitis Symptoms and Method Thereof
08/21/2008US20080200674 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents;Alzheimer's disease; anticancer agents
08/21/2008US20080200653 Compositions and methods for the diagnosis and treatment of tumor
08/21/2008US20080200563 Non-invasive administering active materials; absorption iimproved using glutathione with active material; matric tablets, capsules
08/21/2008US20080200559 Reducing fat; using ace inhibitor
08/21/2008US20080200558 Inhibitory or blocking agents of molecular generating and/or/ inducing functions
08/21/2008US20080200557 N-substituted dopamine derivatives; septic shock, microbial infection, carcinogenesis, a mutation, Parkinson's or Alzheimer's disease, toxic effects of chemotherapy or radiation therapy; N-acetyldopamine; 3-methoxy dopamine
08/21/2008US20080200556 Amine Compounds And Inhibiting Neurotrasmitter Reuptake
08/21/2008US20080200555 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
08/21/2008US20080200553 N-[2-Chloro-4-pentafluorosulfanylbenzoyl]guanidine; ischemia, reperfusion, arrythmia angina pectoris; inhibit the cellular sodium-proton antiporter (Na+/H+ exchanger, NHE); stability, longer half-life in vivo, high bioavailability
08/21/2008US20080200552 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; 2-(4-{1-Ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-2-methyl-benzoylamino)-2-methyl-propionic acid
08/21/2008US20080200551 Flourene Derivative
1 ... 3121 3122 3123 3124 3125 3126 3127 3128 3129 3130 3131 3132 3133 3134 3135 3136 3137 3138 3139 3140 3141 ... 7860